It is just not going to happen....way too many warrants at .70/.80 from most recent offerings and warrants galore beyond those...Going from .45 range to current prices, it needed to consolidate. Today has seen it fall through some moving averages, so could head lower to the 200 day support. If it breaks that, could easily see it back to .60s sooner rather than later. If they announce any new licensening deals (depending on location/scope) or they have actually filed with the FDA...then all bets are off, but they did not project that until early 2018...so just a waiting game at this point. Hopefully they are moving out with other pipeline, but doing so in a cost efficient manner. Spana is good at one thing without a doubt and that is burning through money....he is an expert!!!
He is also the number one reason, when I do invest, I will be as active as possible in the company to see that he and others in the company are removed...
News 
Market Data 
Discover 
